HRPP has a One Application Policy in accordance with Title 45 CFR 46.115 (Health and Human Services, IRB Records) and Title 21 CFR 56.115 (Food and Drug Administration, IRB Records). 

All new initial studies (Exempt/Expedited/Full Board) reviewed by the IRB/HRPP after May 1, 2022 will be subject to the One Application Policy. Studies that receive IRB approval or an Exempt Determination will  receive documents stamped with IRB/HRPP Approval that must be retained in their study record. HRPP will issue an updated version of the IRB/HRPP Approved stamped documents with each subsequent submission approval.

New Submissions

Studies that fall under the One Application Policy will maintain a single, active application that reflects current study procedures and incorporates all IRB-approved amendments and HRPP-accepted modifications. Stamped documents will be issued to the PI along with the Approval Memo for all initial approvals. The IRB/HRPP Approved stamp will be located in the footer of the document. The stamped document must be retained in your study records.